From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.18
First Reported 2000
Last Reported 2010
Negated 0
Speculated 1
Reported most in Abstract
Documents 4
Total Number 4
Disease Relevance 2.24
Pain Relevance 0.38

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytoskeleton (SGCB) cytoskeleton organization (SGCB) cytoplasm (SGCB)
Anatomy Link Frequency
SGCB (Homo sapiens)
Pain Link Frequency Relevance Heat
Dopamine 2 91.52 High High
nud 2 76.44 Quite High
Morphine 1 76.40 Quite High
abdominal pain 2 75.48 Quite High
Bioavailability 4 29.28 Quite Low
palliative 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Carcinoma 91 100.00 Very High Very High Very High
Acquired Immune Deficiency Syndrome Or Hiv Infection 22 93.48 High High
Diarrhoea 4 90.36 High High
Infection 14 89.08 High High
Dyspepsia 2 76.44 Quite High
Vomiting 4 75.88 Quite High
Abdominal Pain 2 75.48 Quite High
Cancer 42 34.12 Quite Low
Disease 7 5.00 Very Low Very Low Very Low
Adenoid Cystic Carcinoma 5 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Our results suggest that SPHK1 expression is associated with SGC progression, and might represent as a novel and valuable predictor for adjuvant therapy to SGC patients.

SGC Spec (might) Binding (associated) of associated with carcinoma
1) Confidence 0.18 Published 2010 Journal BMC Cancer Section Abstract Doc Link PMC2949806 Disease Relevance 0.49 Pain Relevance 0
Compared with the HGC formulation, saquinavir SGC appears to be associated with a higher overall incidence of adverse events.
SGC Binding (associated) of in SGC
2) Confidence 0.05 Published 2000 Journal Drugs Section Abstract Doc Link 10983742 Disease Relevance 0.69 Pain Relevance 0.11
Triple therapy with saquinavir SGC plus 2 NRTIs was as effective as nelfinavir-containing triple therapy, or quadruple therapy (saquinavir SGC plus 2 NRTIs plus nelfinavir) in markedly suppressing HIV RNA levels in antiretroviral therapy-experienced or -naive patients.
SGC Binding (therapy) of in SGC associated with acquired immune deficiency syndrome or hiv infection
3) Confidence 0.04 Published 2000 Journal Drugs Section Abstract Doc Link 10983742 Disease Relevance 1.07 Pain Relevance 0.11
NCS exhibits 28-38% identity, and putative structural homology, with the Bet v 1 allergen and pathogenesis-related (PR)10 protein families.
families Binding (exhibits) of
4) Confidence 0.00 Published 2004 Journal Plant J. Section Abstract Doc Link 15447655 Disease Relevance 0 Pain Relevance 0.16

General Comments

This test has worked.

Personal tools